Ajanta Pharma signs pact with Biocon for Semaglutide
[ad_1] Ajanta Pharma has entered into an in-licensing agreement with Biocon for Semaglutide. Under the agreement, Biocon will supply Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, the Middle East and Central Asia. A GLP-1 receptor agonist, Semaglutide is to improve glycaemic control in adults. In […]
Continue Reading